479 related articles for article (PubMed ID: 21620952)
1. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
[TBL] [Abstract][Full Text] [Related]
2. Cytokine changes and tryptophan metabolites in medication-naïve and medication-free schizophrenic patients.
Kim YK; Myint AM; Verkerk R; Scharpe S; Steinbusch H; Leonard B
Neuropsychobiology; 2009; 59(2):123-9. PubMed ID: 19390223
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan breakdown pathway in bipolar mania.
Myint AM; Kim YK; Verkerk R; Park SH; Scharpé S; Steinbusch HW; Leonard BE
J Affect Disord; 2007 Sep; 102(1-3):65-72. PubMed ID: 17270276
[TBL] [Abstract][Full Text] [Related]
4. [New prospects for antipsychotic treatment - the role of the kynurenine pathway].
Karakuła-Juchnowicz H; Flis M; Szymona K; Kuczyńska M; Stelmach E; Kowal-Popczak A
Psychiatr Pol; 2014; 48(6):1167-77. PubMed ID: 25717486
[TBL] [Abstract][Full Text] [Related]
5. 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.
Condray R; Dougherty GG; Keshavan MS; Reddy RD; Haas GL; Montrose DM; Matson WR; McEvoy J; Kaddurah-Daouk R; Yao JK
Int J Neuropsychopharmacol; 2011 Jul; 14(6):756-67. PubMed ID: 21275080
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
Barry S; Clarke G; Scully P; Dinan TG
J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
[TBL] [Abstract][Full Text] [Related]
7. Increased cortical kynurenate content in schizophrenia.
Schwarcz R; Rassoulpour A; Wu HQ; Medoff D; Tamminga CA; Roberts RC
Biol Psychiatry; 2001 Oct; 50(7):521-30. PubMed ID: 11600105
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
9. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
[TBL] [Abstract][Full Text] [Related]
10. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
[TBL] [Abstract][Full Text] [Related]
12. Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry.
de Jong WH; Smit R; Bakker SJ; de Vries EG; Kema IP
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):603-9. PubMed ID: 19196554
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of indoleamine 2,3-dioxygenase expression and kynurenine pathway metabolites levels in serum samples of diabetic retinopathy patients.
Munipally PK; Agraharm SG; Valavala VK; Gundae S; Turlapati NR
Arch Physiol Biochem; 2011 Dec; 117(5):254-8. PubMed ID: 22034910
[TBL] [Abstract][Full Text] [Related]
14. Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment.
Möller M; Du Preez JL; Emsley R; Harvey BH
Neuropharmacology; 2012 Jun; 62(8):2499-506. PubMed ID: 22426240
[TBL] [Abstract][Full Text] [Related]
15. Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway.
Zsizsik BK; Hardeland R
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Nov; 133(3):383-92. PubMed ID: 12379423
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the tryptophan--nicotinic acid metabolism in vitiligo.
De Antoni A; Cardin Dè Stefani EL; Costa C; Vanzan S; Allegri G
Acta Vitaminol Enzymol; 1982; 4(3):237-43. PubMed ID: 7148608
[TBL] [Abstract][Full Text] [Related]
17. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
[TBL] [Abstract][Full Text] [Related]
18. Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension.
Jasiewicz M; Moniuszko M; Pawlak D; Knapp M; Rusak M; Kazimierczyk R; Musial WJ; Dabrowska M; Kaminski KA
Heart; 2016 Feb; 102(3):230-7. PubMed ID: 26769378
[TBL] [Abstract][Full Text] [Related]
19. Serum kynurenic acid is reduced in affective psychosis.
Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine pathway in major depression: evidence of impaired neuroprotection.
Myint AM; Kim YK; Verkerk R; Scharpé S; Steinbusch H; Leonard B
J Affect Disord; 2007 Feb; 98(1-2):143-51. PubMed ID: 16952400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
